MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 06:05:34 28/06/2024 pm IST | ||
| 8.75 EUR | -0.23% |
|
| Current month | -3.20% | ||
| 1 month | -8.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 8.75 | -0.23% |
| 27/24/27 | 8.77 | -5.70% |
| 26/24/26 | 9.3 | -0.32% |
| 25/24/25 | 9.33 | +3.78% |
| 24/24/24 | 8.99 | -3.12% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 06:05 pm IST
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ5S1F |
| ISIN | DE000DJ5S1F1 |
| Date issued | 26/10/2023 |
| Strike | 321.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.4 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.41 € |
|---|---|
| Lowest since issue | 4.86 € |
| Spread | 0.06 € |
| Spread % | 0.68% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
228.7
USD
Average target price
283.2
USD
Spread / Average Target
+23.80%
- Stock Market
- Certificates
- Certificat
